Nadiflo

Nadiflo may be available in the countries listed below.

Ingredient matches for Nadiflo

Nadifloxacin

Nadifloxacin is reported as an ingredient of Nadiflo in the following countries:

• Japan

International Drug Name Search

Hormodose

Hormodose may be available in the countries listed below.

Ingredient matches for Hormodose

Estradiol

Estradiol is reported as an ingredient of Hormodose in the following countries:

• Brazil

International Drug Name Search

Lotemax

Lotemax is a brand name of loteprednol ophthalmic, approved by the FDA in the following formulation(s):

LOTEMAX (loteprednol etabonate - ointment; ophthalmic)

• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: April 15, 2011
  
  Strength(s): 0.5% ^[RLD]

LOTEMAX (loteprednol etabonate - suspension/drops; ophthalmic)

• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: March 9, 1998
  
  Strength(s): 0.5% ^[RLD]

Has a generic version of Lotemax been approved?

No. There is currently no therapeutically equivalent version of Lotemax available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lotemax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Soft steroids having anti-inflammatory activity
  Patent 4,996,335
  Issued: February 26, 1991
  Inventor(s): Bodor; Nicholas S.
  Assignee(s): Bodor; Nicholas S.
  The invention provides novel soft steroidal anti-inflammatory agents, pharmaceutical compositions containing said agents, and methods of administering same to mammals in the treatment of inflammation. Preferred compounds of the invention include haloalkyl 17.alpha.-alkoxycarbonyloxy-11.beta.-hydroxyandrost-4-en-3-one-17.beta.-ca rboxylates and the corresponding .DELTA..sup.1,4 compounds, optionally bearing 6.alpha.- and/or 9.alpha.-fluorine and 16.alpha.- or 16.beta.-methyl substituents. Especially preferred compounds include haloalkyl 17.alpha.-alkoxycarbonyloxy-9.alpha.-fluoro-11.beta.-hydroxy-16-methylandr osta-1,4-dien-3-one-17.beta.-carboxylates.
  
  Patent expiration dates:
  
  
  • March 9, 2012
    
  
  
  
  • September 9, 2012
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Suspension of loteprednol etabonate for ear, eye, or nose treatment
  Patent 5,540,930
  Issued: July 30, 1996
  Inventor(s): Guy; Yaacov J. & Friedman; Doron I.
  Assignee(s): Pharmos Corporation
  The invention provides novel compositions of matter containing water-insoluble steroid drugs suitable for therapeutic use. The invention provides stable aqueous suspensions of water-insoluble steroid drugs of particle sizes of .ltoreq.15 .mu.m which remain in such a state so as to allow for immediate suspension, when desired, even after extended periods of settling.
  
  Patent expiration dates:
  
  
  • October 25, 2013
    
  
  
  
  • April 25, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Suspension of loteprednol etabonate for ear, eye, or nose treatment
  Patent 5,747,061
  Issued: May 5, 1998
  Inventor(s): Amselem; Shimon & Friedman; Doron
  Assignee(s): Pharmos Corporation
  The invention provides novel compositions of matter for delivering water-insoluble steroid drugs suitable for therapeutic use. The invention also provides stable aqueous suspensions of water-insoluble steroid drugs of particle sizes of .ltoreq.30 .mu.m which remain in such a state so as to allow for immediate suspension, when desired, even after extended periods of settling.
  
  Patent expiration dates:
  
  
  • October 25, 2013
    
    ✓ 
    Patent use: LOTEMAX OPTHALMIC SUSPENSION IS INDICATED FOR THE TREATMENT OF STEROID RESPONSIVE CONDITIONS OF THE PALPEBRAL BULBAR CONJUNCTIVA, CORNEA AND ANTERIOR SEGMENT OF THE GLOBE.
    ✓ 
    Drug product
  
  
  
  • April 25, 2014
    
    ✓ 
    Pediatric exclusivity
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • April 15, 2014 - NEW DOSAGE FORM
  
  
  • October 15, 2014 - PEDIATRIC EXCLUSIVITY
  
  

See also...

• Lotemax Drops Consumer Information (Wolters Kluwer)
• Lotemax Ointment Consumer Information (Wolters Kluwer)
• Lotemax Consumer Information (Cerner Multum)
• Lotemax Advanced Consumer Information (Micromedex)
• Loteprednol Drops Consumer Information (Wolters Kluwer)
• Loteprednol Ointment Consumer Information (Wolters Kluwer)
• Loteprednol ophthalmic Consumer Information (Cerner Multum)
• Loteprednol Ophthalmic Advanced Consumer Information (Micromedex)
• Loteprednol Etabonate AHFS DI Monographs (ASHP)

Mibolerone

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0003704-09-4

Chemical Formula

C20-H30-O2

Molecular Weight

302

Therapeutic Categories

Anabolic

Androgen

Chemical Name

Estr-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7α,17ß)-

Foreign Names

• Miboleronum (Latin)
• Miboleron (German)
• Mibolérone (French)
• Mibolerona (Spanish)

Generic Names

• Mibolerone (OS: USAN, BAN)
• Mibolérone (OS: DCF)
• U 10997 (IS: Upjohn)
• Mibolerone (PH: USP 32)

Brand Name

• Cheque (veterinary use)
  Pharmacia & Upjohn vet, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Aluminium

In some countries, this medicine may only be approved for veterinary use.

Scheme

BP

CAS registry number (Chemical Abstracts Service)

0007429-90-5

Chemical Formula

Al

Molecular Weight

26

Therapeutic Categories

Wound healing agent

Dermatological agent: Skin protectant

Foreign Names

• Aluminium (Latin)
• Aluminium (German)
• Aluminium (French)
• Aluminio (Spanish)

Generic Names

• CI 77000 (IS)
• E173 (IS)
• Glin (IS)
• Aluminium Powder (PH: BP 2010)

Brand Name

• Aluspray (veterinary use)
  Laboratoire Vétoquinol, France

International Drug Name Search

Glossary

BP	British Pharmacopoeia
IS	Inofficial Synonym
PH	Pharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Alprazolam AL

Alprazolam AL may be available in the countries listed below.

Ingredient matches for Alprazolam AL

Alprazolam

Alprazolam is reported as an ingredient of Alprazolam AL in the following countries:

• Germany

International Drug Name Search

BroveX PB C

Pronunciation: FEN-il-EF-rin/BROME-fen-IR-a-meen/KOE-deen
Generic Name: Phenylephrine/Brompheniramine/Codeine
Brand Name: Examples include BroveX PB C and BroveX PB CX

BroveX PB C is used for:

Relieving symptoms of sinus congestion, runny nose, sneezing, and cough due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.

BroveX PB C is a decongestant, antihistamine, and cough suppressant combination. The decongestant works by constricting blood vessels and reducing swelling in the nasal passages. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The cough suppressant works in the brain to help decrease the cough reflex to reduce a dry cough.

Do NOT use BroveX PB C if:

• you are allergic to any ingredient in BroveX PB C or any other codeine- or morphine-related medicine (eg, oxycodone)


• you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, severe heart problems, peptic ulcer, narrow-angle glaucoma, difficulty urinating, or are having an asthma attack


• you take sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using BroveX PB C:

Some medical conditions may interact with BroveX PB C. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat


• if you have a history of adrenal gland problems (eg, adrenal gland tumor); heart problems (eg, heart disease); high or low blood pressure; low blood volume; diabetes; blood vessel problems; stroke; glaucoma; a blockage of your stomach, bladder, or intestines; trouble urinating; an enlarged prostate or other prostate problems; mental or mood problems (eg, depression); pancreas problems (eg, pancreatitis); or thyroid problems


• if you have a history of asthma or other breathing problems, chronic cough, lung problems (eg, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus


• if you have severe drowsiness, recent head or brain injury, brain tumor, increased pressure in the brain, infection of the brain or nervous system, or a seizure disorder (eg, epilepsy)


• if you have a history of constipation, stomach problems (eg, ulcers), bowel problems (eg, chronic inflammation or ulceration of the bowel), or gallbladder problems (eg, gallstones), or if you have had recent stomach, bowel, or urinary surgery


• if you have a history of alcohol abuse, drug abuse, or suicidal thoughts or behavior; or if you are in poor health or are very overweight


• if you take medicine for high blood pressure or depression

Some MEDICINES MAY INTERACT with BroveX PB C. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), cimetidine, furazolidone, HIV protease inhibitors (eg, ritonavir), MAOIs (eg, phenelzine), muscle relaxants (eg, cyclobenzaprine), opioid analgesics (eg, hydrocodone), phenothiazines (eg, chlorpromazine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of BroveX PB C's side effects


• Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased


• Naltrexone, quinidine, or rifamycins (eg, rifampin) because they may decrease BroveX PB C's effectiveness


• Bromocriptine or hydantoins (eg, phenytoin) because the risk of their side effects may be increased by BroveX PB C


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by BroveX PB C

This may not be a complete list of all interactions that may occur. Ask your health care provider if BroveX PB C may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use BroveX PB C:

Use BroveX PB C as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take BroveX PB C by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Take BroveX PB C with a full glass of water (8 oz/240 mL).


• Drink plenty of water while taking BroveX PB C.


• If you miss a dose of BroveX PB C, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use BroveX PB C.

Important safety information:

• BroveX PB C may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use BroveX PB C with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• BroveX PB C may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, muscle relaxers, sleep aids) while you are using BroveX PB C; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Do not take diet or appetite control medicines while you take BroveX PB C without checking with your doctor.


• BroveX PB C has phenylephrine and brompheniramine in it. Before you start any new medicine, check the label to see if it has phenylephrine or brompheniramine in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Do not use BroveX PB C for a cough with a lot of mucus. Do not use it for a long-term cough (eg, caused by asthma, emphysema, smoking). However, you may use it for these conditions if your doctor tells you to.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• If your symptoms do not get better within 5 days, if they get worse, or if they occur along with a fever, check with your doctor.


• BroveX PB C may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to BroveX PB C. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• BroveX PB C may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking BroveX PB C for a few days before the tests.


• Tell your doctor or dentist that you take BroveX PB C before you receive any medical or dental care, emergency care, or surgery.


• Use BroveX PB C with caution in the ELDERLY; they may be more sensitive to its effects, especially confusion, dizziness, drowsiness, low blood pressure, excitability, dry mouth, and trouble urinating.


• Caution is advised when using BroveX PB C in CHILDREN; they may be more sensitive to its effects, especially excitability.


• BroveX PB C should not be used in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using BroveX PB C while you are pregnant. Do not take BroveX PB C in the third trimester of pregnancy. It is not known if BroveX PB C is found in breast milk. Do not breast-feed while taking BroveX PB C.

Some people who use BroveX PB C for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction.

If you stop taking BroveX PB C suddenly, you may have WITHDRAWAL symptoms. These may include anxiety, irregular heartbeat, irritability, restlessness, trouble sleeping, and unusual sweating.

Possible side effects of BroveX PB C:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; dry mouth, nose, or throat; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; difficulty urinating or inability to urinate; fast, slow, or irregular heartbeat; hallucinations; loss of coordination; mental or mood changes (eg, irritability); ringing in the ears; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; shallow breathing; tremor; trouble sleeping; uncontrolled muscle movements; unusual bruising or bleeding; unusual weakness or tiredness; vision changes or blurred vision.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch .

See also: BroveX PB C side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; cold and clammy skin; coma; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; shallow breathing; unusually fast, slow, or irregular heartbeat; vomiting.

Proper storage of BroveX PB C:

Store BroveX PB C at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep BroveX PB C out of the reach of children and away from pets.

General information:

• If you have any questions about BroveX PB C, please talk with your doctor, pharmacist, or other health care provider.


• BroveX PB C is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about BroveX PB C. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More BroveX PB C resources

• BroveX PB C Side Effects (in more detail)
• BroveX PB C Use in Pregnancy & Breastfeeding
• BroveX PB C Drug Interactions
• 0 Reviews for BroveX PB C - Add your own review/rating

Compare BroveX PB C with other medications

• Cold Symptoms
• Cough and Nasal Congestion